Halftime Report Panelist 2

Crypto Analyst, CoinDesk
· tracked since Aug 2026
Calls
1
Win Rate
0.0%
return
-4.5%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 1
Win Rate 0% Long 1 Short 0
Win Rate
7d 0%
30d 100%
90d —
Average Return -4.5% Long Return -4.5% Short Return -
Average Return
7d -3.5%
30d +3.2%
90d —
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
BMY 1ST Bristol ... Bristol Myers Squibb
Long
Aug 04
$65.95
-4.5%
Cheap, dividend, pipeline complements oncology.
Bristol-Myers Squibb is exceptionally cheap, has a good dividend yield, and possesses a pipeline that complements AstraZeneca’s oncology focus, particularly in cardiovascular, despite the negative market reaction to the rumored deal.
Pharma & Biotech
YOUTUBE
Showing 1 of 1 calls · sorted by mentions

Halftime Report Panelist 2 has 1 trade ideas tracked on Buzzberg across 1 tickers since August 2026. Most covered: BMY.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology